Wendell David Associates Inc Amgen Inc Transaction History

Wendell David Associates Inc

$1.05 Billion
Q3 2024

A detailed history of Wendell David Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Wendell David Associates Inc holds 11,547 shares of AMGN stock, worth $3.03 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

11,547

Previous 11,423 1.09%

Holding current value

$3.03 Million

Previous $3.57 Million 4.26%

% of portfolio

0.36%

Previous 0.36%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$309.38 - $337.38 $38,363 - $41,835	124 Added 1.09%	11,547 $3.72 Million
Q2 2024 Jul 22, 2024	SELL	$262.75 - $319.31 $6,568 - $7,982	-25 Reduced 0.22%	11,423 $3.57 Million
Q1 2024 Apr 22, 2024	BUY	$268.87 - $324.56 $6,184 - $7,464	23 Added 0.2%	11,448 $3.26 Million
Q4 2023 Jan 22, 2024	BUY	$255.7 - $288.46 $7,671 - $8,653	30 Added 0.26%	11,425 $3.29 Million
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $4,285 - $5,067	-20 Reduced 0.18%	11,395 $2.53 Million
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $25,812 - $29,112	-115 Reduced 1.0%	11,415 $2.57 Million
Q2 2022 Jul 14, 2022	SELL	$230.71 - $256.74 $92,284 - $102,696	-400 Reduced 3.35%	11,530 $2.81 Million
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $125,493 - $143,615	631 Added 5.58%	11,930 $2.68 Million
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $4,204 - $4,664	-18 Reduced 0.16%	11,299 $2.75 Million
Q1 2021 Apr 20, 2021	BUY	$221.91 - $258.6 $221 - $258	1 Added 0.01%	11,317 $2.82 Million
Q4 2020 Jan 22, 2021	SELL	$216.38 - $257.67 $37,000 - $44,061	-171 Reduced 1.49%	11,316 $2.6 Million
Q1 2020 Apr 16, 2020	SELL	$182.24 - $241.7 $13,850 - $18,369	-76 Reduced 0.66%	11,487 $2.33 Million
Q1 2019 Apr 11, 2019	BUY	$180.87 - $203.88 $6,149 - $6,931	34 Added 0.29%	11,563 $2.2 Million
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $77,604 - $90,588	-435 Reduced 3.64%	11,529 $2.24 Million
Q1 2018 Apr 11, 2018	SELL	$169.43 - $198.0 $16,773 - $19,602	-99 Reduced 0.82%	11,964 $2.04 Million
Q4 2017 Jan 16, 2018	SELL	$168.79 - $188.59 $40,003 - $44,695	-237 Reduced 1.93%	12,063 $2.1 Million
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $2.06 Million - $2.35 Million	12,300	12,300 $2.29 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Account

Wendell David Associates Inc Amgen Inc Transaction History